Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Position in McKesson Corporation $MCK

Posted by Stanley Muller on Jul 3rd, 2026

Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 38.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,237 shares of the company’s stock after acquiring an additional 21,544 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in McKesson were worth $66,838,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of MCK. Cullen Investment Group LTD. boosted its position in shares of McKesson by 550.4% in the fourth quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company’s stock worth $3,811,000 after purchasing an additional 3,952 shares during the period. Pensionfund Sabic bought a new stake in McKesson during the fourth quarter valued at about $1,887,000. Investment Research Partners LLC purchased a new position in shares of McKesson in the third quarter valued at about $1,303,000. Achmea Investment Management B.V. lifted its position in shares of McKesson by 7.5% in the third quarter. Achmea Investment Management B.V. now owns 61,287 shares of the company’s stock valued at $47,347,000 after acquiring an additional 4,260 shares in the last quarter. Finally, Horizon Investments LLC boosted its stake in shares of McKesson by 125.4% in the fourth quarter. Horizon Investments LLC now owns 8,679 shares of the company’s stock worth $7,119,000 after acquiring an additional 4,828 shares during the period. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Trading Up 2.4%

Shares of MCK stock opened at $786.17 on Friday. The stock has a market capitalization of $92.05 billion, a price-to-earnings ratio of 20.44, a price-to-earnings-growth ratio of 1.26 and a beta of 0.31. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The stock’s 50-day moving average price is $770.09 and its 200-day moving average price is $839.35.

McKesson (NYSE:MCK – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The company had revenue of $96.30 billion during the quarter, compared to analyst estimates of $101.35 billion. During the same period in the prior year, the company earned $10.12 earnings per share. The firm’s revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, research analysts predict that McKesson Corporation will post 44.28 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 1st. Investors of record on Monday, June 1st were issued a $0.82 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 8.53%.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,463 shares of the stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of $775.13, for a total transaction of $6,559,925.19. Following the completion of the transaction, the chief executive officer owned 14,382 shares in the company, valued at $11,147,919.66. This trade represents a 37.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 699 shares of McKesson stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $735.27, for a total transaction of $513,953.73. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,667,592.36. The trade was a 23.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 20,285 shares of company stock worth $15,546,137. Company insiders own 0.06% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on MCK shares. Leerink Partners reiterated an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, June 27th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Barclays reduced their price objective on shares of McKesson from $1,050.00 to $925.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. Finally, Weiss Ratings downgraded shares of McKesson from a “buy (b+)” rating to a “buy (b)” rating in a report on Monday, May 18th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $960.53.

View Our Latest Analysis on MCK

About McKesson

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.